1.	Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer Phase: Phase II Type: Diagnostic Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: TMH/115/2003, No.5/13/66/2003-NCD-III, NCT00128362
2.	Axillary Reverse Mapping Phase: Phase II Type: Treatment Status: Active Age: 18 to 100 Sponsor: Other Protocol IDs: UAMS 78076, NCT00572481
3.	Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation Phase: Phase II Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UAMS 04959, NCT00575744
4.	Breast Lymph Node Mapping Phase: Phase II Type: Diagnostic Status: Approved-not yet active Age: 19 to 100 Sponsor: Other Protocol IDs: H09-00926, NCT01038908
5.	Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 03-0031, NCT00315159
6.	Sentinel Node in Colon Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 3737, NCT00411112
7.	Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer Phase: No phase specified Type: Diagnostic, Health services research Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: caugs_01, NCT00654342
8.	Pilot Indocyanine Green™ Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer Phase: No phase specified Type: Diagnostic Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: BRS0022, SU-06122012-10130, 21030, NCT01771666
9.	Lymph Node Mapping in Patients With Endometrial Cancer Phase: No phase specified Type: Diagnostic Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: OSU-12114, NCI-2013-00530, NCT01818739